Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373061 · ClinicalTrials.gov registry record
An Observational Study of the Use and Safety of Xolair® During Pregnancy
A clinical trial, sponsored by Genentech.
- Completed
- Registry status
- 309
- Enrollment target
NCT00373061 is a clinical trial that has completed, run by Genentech. The registered enrollment target is 309 participants.
The verdict
NCT00373061 has completed, sponsored by Genentech.
- COMPLETED
- Registry status
- 309 participants
- Enrollment target
Study Summary
The Xolair® Pregnancy Registry is an observational study established by Genentech to obtain data on pregnancy outcomes in women who are exposed to Xolair®. Women exposed to at least one dose of Xolair® within 8 weeks prior to conception or at any time during their pregnancy will be followed to completion of their pregnancies. The evaluation of infants will be conducted at birth and at 6-month intervals until the infants are 12 months old. Follow-up of the infant will be extended until the infant is 18 months old, if the woman continues Xolair® treatment while breastfeeding.
Interventions
- DRUG Xolair®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 309 participants |
| Start Date | 2006-10-20 |
| Est. Completion | 2018-01-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00373061
The ClinicalTrials.gov registry entry for NCT00373061 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 309 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Genentech, which has 332 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Xolair® is the first listed.
NCT00373061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00373061 about?
NCT00373061 is a clinical study titled "An Observational Study of the Use and Safety of Xolair® During Pregnancy". The Xolair® Pregnancy Registry is an observational study established by Genentech to obtain data on pregnancy outcomes in women who are exposed to Xolair®. Women exposed to at least one dose of Xolair® within 8 weeks prior to conception or at any time during their pregnancy will be followed to compl...
What is the current status of trial NCT00373061?
This trial is currently completed. The enrollment target is 309 participants. The study started on 2006-10-20. Estimated completion is 2018-01-05.
What interventions are being tested in trial NCT00373061?
The interventions under investigation include: Xolair® (DRUG).
Who is sponsoring clinical trial NCT00373061?
This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.